Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
WHO issues its first hepatitis B treatment guidelines

WHO today issued its first-ever guidance for the treatment of chronic hepatitis B, a viral infection which is spread through blood and body fluids, attacking the liver and resulting in an estimated 650 000 deaths each year – most of them in low- and middle-income countries.

Published
12 March 2015
From
World Health Organization
Hepatitis Quest Moves From C to B Under Former Gilead Executives

Gilead Sciences Inc. raked in $10 billion last year with its Sovaldi pill for hepatitis C. Many of the people responsible for the drug are now competing to repeat that success for a more common liver disease: hepatitis B.

Published
05 February 2015
From
Bloomberg
Experimental siRNA therapy lowers HBsAg levels in people with hepatitis B

ARC-520, a novel therapy using short interfering RNA, appeared safe and was associated with a reduction in hepatitis B surface antigen levels in people with chronic hepatitis

Published
06 January 2015
By
Liz Highleyman
New open-access journal in the rapidly developing field of virus eradication

The Journal of Virus Eradication is a new open-access online and print journal dedicated to the rapidly developing field of virus eradication. It is particularly interested in publishing original research on HIV, hepatitis viruses, HPV, herpes and flu but work on other viruses is also included. The first issue was successfully launched at the HIV and Hepatitis Five Nations Conference in London on 8 December 2014 and is available now on the Journal website: www.viruseradication.com

Published
23 December 2014
From
Mediscript
Entecavir and tenofovir work well for people with drug-resistant hepatitis B virus

A combination of entecavir plus tenofovir effectively suppressed hepatitis B virus (HBV) in people with resistance to other antivirals, according to results from the European ENTEBE study

Published
22 December 2014
By
Liz Highleyman
Tenofovir continues to suppress hepatitis B virus for eight years

Most people with chronic hepatitis B who are treated with tenofovir for eight years continued to maintain viral suppression, researchers reported at the American Association for the Study

Published
25 November 2014
By
Liz Highleyman
Adding pegylated interferon to tenofovir improves odds of HBsAg loss in hepatitis B patients

People with chronic hepatitis B virus (HBV) infection are more likely to experience favourable treatment response, as indicated by hepatitis B surface antigen (HBsAg) loss, if they add

Published
17 November 2014
By
Liz Highleyman
People living with HIV have high survival rates after liver transplants due to HCC

People with HIV – most of whom had hepatitis B or C co-infection – generally had good outcomes after liver transplantation due to hepatocellular carcinoma (HCC), with

Published
12 November 2014
By
Liz Highleyman
Hepatitis B testing and treatment rates are low among US veterans

Only 15% of US veterans have been tested for hepatitis B virus (HBV) infection, and among those who tested positive just one-quarter received antiviral treatment and 13%

Published
11 November 2014
By
Liz Highleyman
People with hepatitis B who have cirrhosis should be prioritised for liver cancer screening

Liver cancer screening for people with hepatitis B virus (HBV) infection should be targeted at those with cirrhosis, according to the results of a systematic review and meta-analysis

Published
02 October 2014
By
Michael Carter
← First12345...11Next →

Filter by country